MMA Summit

Speakers

Don't miss the world class line-up of international researchers and leaders, alongside Mind Medicine Australia Ambassadors that are gathering at the summit to help us expand the treatment paradigm for mental health.

Professor David Nutt (UK)

Head of Neuropsychopharmacology at Imperial College London

Professor David Nutt (UK)

Head of Neuropsychopharmacology at Imperial College London

BA, MB BChir, MRCP, MA, DM, MRCPsych, FRCPsych, FMedSci, FRCP, FSB.

Renowned researcher, policy advisor and author, Professor David Nutt, is currently Head of Neuropsychopharmacology at Imperial College London.

Under the leadership of Professor Nutt, the Psychedelic Research Group at Imperial College is one of the world’s foremost psychedelic research laboratories, publishing landmark research on psychedelic therapies and neuroimaging studies of the psychedelic state.

Professor Nutt has also held many leadership positions in both UK and European academic, scientific and clinical organisations, including presidencies of: the European Brain Council, the British Neuroscience Association, the British Association of Psychopharmacology, the European College of Neuropsychopharmacology.

He was previously Chair of the UK Advisory Council on the Misuse of Drugs.

John Skerrit

Deputy Secretary, Health Products Regulation Group- TGA

John Skerrit

Deputy Secretary, Health Products Regulation Group- TGA

Adjunct Professor John Skerritt joined the Australian Department of Health in 2012 as a Deputy Secretary. Apart from being part of the Executive team of Australia’s national Health Department, responsible for the Federal government’s $100 billion investment in health, aged care and sport he also has line responsibility for the Therapeutic Goods Administration and the Office of Drug Control. He was formerly a Deputy Secretary in the Victorian Government, Deputy CEO of a Commonwealth Statutory Authority in the Australian overseas aid program, senior research manager in CSIRO and in industry joint venture partnerships. From 2009-2012, he was Chair of the Board of a global technical non-government organisation, and was a board member for two further years. John is an Adjunct Full Professor in medicine, pharmacy and agriculture at three Universities, has a PhD and a University Medal from the University of Sydney, and is a graduate of the Senior Executive Programs of London Business School and of the International Institute for Management Development in Switzerland. He was elected a Fellow of the Academy of Technological Sciences and Engineering and a Fellow of the Institute of Public Administration of Australia (Vic).

Dr Rick Doblin (USA)

Executive Director of MAPS

Dr Rick Doblin (USA)

Executive Director of MAPS

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).

He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment.

Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.

He founded MAPS in 1986, and currently resides in Boston with his wife, dog, and empty rooms from three children, one of whom is in college and two have graduated.

Wade Davis CM (Canada)

Professor of Anthropology & BC Leadership Chair in Cultures and Ecosystems at Risk at the University of British Columbia

Wade Davis CM (Canada)

Professor of Anthropology & BC Leadership Chair in Cultures and Ecosystems at Risk at the University of British Columbia

Wade Davis is a writer, photographer, and filmmaker whose work has taken him from the Amazon to Tibet, Africa to Australia, Polynesia to the Arctic. Explorer-in-Residence at the National Geographic Society from 2000 to 2013, he is currently Professor of Anthropology and the BC Leadership Chair in Cultures and Ecosystems at Risk at the University of British Columbia. Author of 22 books, including One River, The Wayfinders and Into the Silence, winner of the 2012 Samuel Johnson prize, the top nonfiction prize in the English language, he holds degrees in anthropology and biology and received his Ph.D. in ethnobotany, all from Harvard University.

His many film credits include Light at the Edge of the World, an eight-hour documentary series written and produced for the NGS. Davis, one of 20 Honorary Members of the Explorers Club, is the recipient of 11 honorary degrees, as well as the 2009 Gold Medal from the Royal Canadian Geographical Society, the 2011 Explorers Medal, the 2012 David Fairchild Medal for botanical exploration, the 2015 Centennial Medal of Harvard University, the 2017 Roy Chapman Andrews Society’s Distinguished Explorer Award, the 2017 Sir Christopher Ondaatje Medal for Exploration, and the 2018 Mungo Park Medal from the Royal Scottish Geographical Society. In 2016, he was made a Member of the Order of Canada. In 2018 he became an Honorary Citizen of Colombia.

Dr Robin Carhart-Harris (UK)

Head of the Centre for Psychedelic Research at Imperial College London

Dr Robin Carhart-Harris (UK)

Head of the Centre for Psychedelic Research at Imperial College London

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, he has run and overseen brain imaging studies involving LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression, and a current study comparing psilocybin with escitalopram for major depressive disorder. In 2019, he set-up the Centre for Psychedelic Research at Imperial and he also an honorary position with the University of Oxford. Two of his most influential works include the ‘Entropic Brain Hypothesis’ and ‘REBUS and the anarchic brain’.

Professor Janis Phelps (USA)

Psychedelic Therapist Trainer

Professor Janis Phelps (USA)

Psychedelic Therapist Trainer

Janis Phelps, PhD, is a full professor at the California Institute of Integral Studies (CIIS), San Francisco, CA. A licensed clinical psychologist, she has held faculty positions there in the East-West Psychology graduate program (founded by Alan Watts) and in the clinical psychology doctoral program. She served as the Dean of Faculty at CIIS for the graduate departments in the School of Humanities and Social Sciences.

She is currently the founder and director of the CIIS Center for Psychedelic Therapies and Research. As the Center’s founder, Dr. Phelps developed and launched the first academically accredited, professional certificate training program for legal psychedelic-assisted therapy and research www.ciis.edu/psychedeliccenter. Her recent publications focus on the competencies, knowledge base, and training of therapists and facilitators in psychedelic-assisted therapies.

Dr. Phelps is contributing to the development of a national accreditation board for facilitators/therapists and to methods of scaling effective and efficient training programs to meet the burgeoning need for well-trained mental health and medical professionals in the field of psychedelic medicine.

Dr Ben Sessa (UK)

Psychiatrist, researcher and writer

Dr Ben Sessa (UK)

Psychiatrist, researcher and writer

Dr Ben Sessa trained at UCL, London, graduating in Medicine in 1997.

He works clinically as an adult and adolescent psychiatrist, and academically in Bristol and Imperial College London University, with an interest in the developmental trajectory from child maltreatment to adult mental health disorders.

In the last ten years Ben has been a study doctor and a test subject administering and receiving legal doses of pure LSD, psilocybin, MDMA, DMT and Ketamine.

He is currently conducting the world’s first clinical study using MDMA to treat addiction. Ben is the co-founder and past President of the UK’s premier psychedelic research conference, Breaking Convention.

He has published dozens of peer reviewed papers on psychedelics and is the Author of several textbooks, including the influential book ‘The Psychedelic Renaissance‘.

Professor Dan Ariely (USA/Israel)

James B. Duke Professor of Psychology and Behavioural Economics at Duke University

Professor Dan Ariely (USA/Israel)

James B. Duke Professor of Psychology and Behavioural Economics at Duke University

Dan Ariely is the James B. Duke Professor of Psychology and Behavioral Economics at Duke University, with appointments in the Fuqua School of Business, the Center for Cognitive Neuroscience, and the department of Economics.

As one of the foremost leaders in psychology and behavioral economics, Dr. Ariely has published his research in top economic, medical and psychology journals and is the author of Predictably Irrational (2008), The Upside of Irrationality (2010), and The (Honest) Truth About Dishonesty (2012), three bestselling general audience books about research in behavioral economics. In addition, he is the founding member of The Center For Advanced Hindsight.

Associate Professor Matthew Johnson (USA)

Associate Director at the Johns Hopkins Center for Psychedelic & Consciousness Research

Associate Professor Matthew Johnson (USA)

Associate Director at the Johns Hopkins Center for Psychedelic & Consciousness Research

Matthew W. Johnson, Ph.D., Associate Professor at Johns Hopkins, is an expert on psychedelics, other drugs, and addiction. Working with psychedelics for >15 years, he has published >100 papers with 43 on psychedelics. Matt published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. He published the first research on psychedelic treatment of tobacco addiction in 2014, and the largest study of psilocybin in treating cancer distress in 2016. His recent psilocybin review recommended placement in Schedule-IV upon medical approval.

He has personally guided >100 psychedelic sessions. Matt also conducts behavioral economic research on both addiction and sexual risk. He has published studies on nearly all psychoactive drugs classes, and is President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association. Matt has been interviewed by the New York Times, Washington Post, Wall Street Journal, BBC, CNN, Fox Business News, NPR, CBS News, and NBC News.

Maria Papaspyrou (UK)

Psychotherapist and writer, Founder TRIPP Network UK

Maria Papaspyrou (UK)

Psychotherapist and writer, Founder TRIPP Network UK

Maria Papaspyrou is an integrative psychotherapist and systemic family constellations facilitator in private practice in Brighton, UK. She has almost twenty years of clinical experience and has worked in the fields of trauma, mental health, student counselling and psychedelic integration.

In the last seven years she has given talks and published articles on the sacramental and healing properties of entheogens, supporting their re-introduction in psychotherapy and is currently co-editing an upcoming anthology on psychedelic psychotherapy and integration. Wanting to promote this work within the psychotherapeutic profession she actively supports the development of psychedelic integration as a field of specialism and has founded TRIPP Network, a U.K. based psychedelic psychotherapy integration database and continuous professional development training forum.

Her more conceptual work focuses on the intersecions between feminine and altered states of consciousness and their capacity to re-awaken our collective ecological consciousness. She has co-edited the book “Psychedelic Mysteries of the Feminine”.

You can find out more about her work at towardswholeness.co.uk

Adam Gazzaley M.D, PHD (USA)

Founder & Executive Director - Neuroscape

Adam Gazzaley M.D, PHD (USA)

Founder & Executive Director - Neuroscape

Dr. Adam Gazzaley obtained an M.D. and a Ph.D. in Neuroscience at the Mount Sinai School of Medicine in New York, completed Neurology residency at the University of Pennsylvania, and postdoctoral training in cognitive neuroscience at University of California, Berkeley. He is now the David Dolby Distinguished Professor in Neurology, Physiology and Psychiatry at University of California, San Francisco and the Founder / Executive Director of Neuroscape, a translational neuroscience center engaged in technology creation and scientific research.

He designs and develops novel brain assessment and optimization tools to impact education, wellness, and medicine practices. This novel approach involves the development of custom-designed, closed-loop video games integrated with the latest advancements in software (brain computer interfaces, GPU computing, cloud-based analytics) and hardware (virtual/augmented reality, motion capture, mobile physiological recording devices, transcranial electrical brain stimulation). These technologies are then advanced to rigorous research studies that evaluate their impact on multiple aspects of brain function and physiology. This utilizes a powerful combination of neurophysiological tools, including functional magnetic resonance imaging (fMRI), electroencephalography (EEG), transcranial magnetic stimulation (TMS).

Shlomi Raz (USA)

Chairman and CEO - Eleusis

Shlomi Raz (USA)

Chairman and CEO - Eleusis

Shlomi is the chairman and founder of Eleusis. Since founding Eleusis in 2013, Shlomi has overseen the company’s corporate and clinical development effort. Prior to founding Eleusis, Shlomi was a Managing Director at Goldman Sachs, and began his corporate career at JPMorgan.

Shlomi holds an MA from New York University and a BS from Georgetown University.

Renee Harvey (UK)

Clinical Psychologist; Honorary Research Fellow at Imperial College London

Renee Harvey (UK)

Clinical Psychologist; Honorary Research Fellow at Imperial College London

Renee is a Clinical Psychologist has had a long career in the UK as a Consultant in the NHS and more recently as an Honorary Research Fellow at Imperial College London in the study of psilocybin for treatment resistant depression. She has been responsible for leading in service development for people with complex emotional needs across Sussex (UK), establishing three specialist services, including staff appointments, training and supervision, and in clinical delivery in these services. She established various training courses and treatment programmes during this time, and regularly delivered lectures and courses at levels ranging from undergraduate and post-graduate trainees in psychology, medicine and psychiatry, various mental health multi-disciplinary teams as well as to members of the public, voluntary sector services and users of services.

Renee specialised in training clinicians in skills for working with individuals with complex needs across the UK as well as internationally, including Europe, and Japan. She has been a regular presenter in this field at conferences nationally and internationally.

Renee’s passion for finding ways to help those suffering with emotional difficulties has led to a keen interest in the resurgence of psychedelic medicine and the unfolding picture presented by the renaissance of research in the field in recent years. She believes it is vital for medical and psychological approaches to work together closely, and in the crucial role of psychological integration in helping participants benefit and consolidate long-term change. Renee was also a key member of developing psychedelic interest groups in Brighton, and in establishing and running a psychedelic Integration Circle in Brighton UK.

Professor David Castle

Chair of Psychiatry, St Vincent's Health & The University of Melbourne

Professor David Castle

Chair of Psychiatry, St Vincent's Health & The University of Melbourne

David Castle is Chair of Psychiatry at St Vincent’s Health and The University of Melbourne. He has wide clinical and research interests, encompassing schizophrenia and related disorders, bipolar disorder, OCD spectrum disorders and disorders of body image.

He has a longstanding interest in the impact of licit and illicit substances on the brain and body and is actively engaged in programmes addressing the physical health of the mentally ill and the mental health of the physically ill. He has published widely in the scientific literature and is a frequent speaker at scientific meetings. His broader interests include music, literature, theatre and art.

Dr Lisa Reynolds (NZ)

Health Psychologist and Director of the University of Auckland’s Health Psychology Practitioner Programme.

Dr Lisa Reynolds (NZ)

Health Psychologist and Director of the University of Auckland’s Health Psychology Practitioner Programme.

Dr Lisa Reynolds is a Health Psychologist and Director of the University of Auckland’s Health Psychology Practitioner Programme. She has worked clinically as a psychologist for over a decade providing support to cancer patients and whānau. Her therapeutic approach draws on mindfulness-based practice, meaning-centred therapy and cognitive behavioural therapy.

Her academic research focusses on the experience of cancer patients and has investigated interventions that support patients in managing treatment, prognosis and palliative care. She has studied the impact of disfigurement, body image distress and challenging emotions (such as disgust), and looked at whether compassion and mindfulness might be helpful in these contexts.

Her current research with advanced cancer patients includes trials investigating whether virtual reality nature experiences can improve quality of life and alleviate spiritual distress, and she is developing a clinical trial to investigate psychedelic microdosing-assisted psychological therapy with advanced cancer patients.

Dr Simon Longstaff AO

Executive Director of The Ethics Centre

Dr Simon Longstaff AO

Executive Director of The Ethics Centre

Dr Simon Longstaff commenced his work as the first Executive Director of The Ethics Centre in 1991. He undertook postgraduate studies in Philosophy as a Member of Magdalene College, Cambridge.

Simon is a Fellow of CPA Australia and in June 2016, was appointed an Honorary Professor at the Australian National University – based at the National Centre for Indigenous Studies. Formerly serving as the inaugural President of The Australian Association for Professional & Applied Ethics, Simon serves on a number of boards and committees across a broad spectrum of activities. He was formerly a Fellow of the World Economic Forum.

Simon’s distinguished career includes being named as one of AFR Boss’ True Leaders for the 21st century. In 2013 Dr Longstaff was made an officer of the Order of Australia (AO) for “distinguished service to the community through the promotion of ethical standards in governance and business, to improving corporate responsibility, and to philosophy.”

Tania de Jong AM

Founder Creative Universe, Creativity Australia, Creative Innovation Global and Mind Medicine Australia

Tania de Jong AM

Founder Creative Universe, Creativity Australia, Creative Innovation Global and Mind Medicine Australia

Tania is an acclaimed Australian soprano and one of Australia’s most successful female entrepreneurs and innovators having developed 5 businesses and 3 charities over the past 3 decades.
She is the Founder of Creative Universe, Creativity Australia, Mind Medicine Australia, Creative Innovation Global, Dimension5 co-working hub, MTA Entertainment & Events, Pot-Pourri and The Song Room.

Tania presents keynote speeches and performs around the world. She has released 10 albums. She works across the public, private, creative and community sectors. Tania’s TED Talk How Singing Together Changes The Brain has sparked international interest.

She was appointed a Member of the Order of Australia in June 2008. In 2018 Tania was named in the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in Australia.

Tania’s mission is to change the world, one voice at a time!

Peter Hunt AM

Investment Banker & engaged Philanthropist; Founder Women's Community Shelters and Mind Medicine Australia

Peter Hunt AM

Investment Banker & engaged Philanthropist; Founder Women's Community Shelters and Mind Medicine Australia

Peter is Chairman and one of the original Founders of Greenhill Australia, a leading Australian corporate advisory firm that is now part of the global Greenhill advisory group. He has been advising local and multi-national companies and governments in Australia for over 25 years.

In the NFP sector, Peter is Chairman, Grameen Australia; Chairman, So They Can, and Director and Founder, Women’s Community Shelters. Peter is also a member of the Advisory Councils of Mission Australia and the Centre for Social Impact. Previous roles in the sector have included Chairman, AMP Foundation; Chairman, Australian String Quartet; Trustee, St Vincent’s Clinic Foundation; a Director, Odyssey House and a Director, St James Ethics Centre.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Tickets

		Second release June 30^*	Final release^*
Platinum 2 Day Event (18-19 November)	2 Day Event + Premium seating + Gala Dinner + Meet the Speakers	$1,320	$1,584
Gold 2 Day Event (18-19 November)	2 Day Event + Gala Dinner	$870	$1,044
Silver 2 Day Event (18-19 November)	2 Day Event	$708	$850
Introductory Workshop in Psychedelic Therapies (16-17 November)		$816	$980
Gala Dinner (18 November)	Gala Dinner	$210	$250
VIP Tables	$5000 donation to Mind Medicine Australia. VIP tables will include places for your 10 guests and have an international leader seated at the table. There are limited VIP tables available so get in early!
Display opportunity	Mind Medicine Australia have an exciting opportunity for your business or organisation to host a display at our International Summit on Psychedelic Therapies for Mental Illness taking place November 18-19 in Melbourne, Australia. An exclusive display will provide maximum brand exposure/awareness and face to face interaction with conference delegates, speakers and VIPs. Contact us for more details.

YOUR 2020 SUMMIT PACKAGE (Platinum, Gold, Silver) includes:

Hot Spot sessions tickets
Morning, Afternoon tea & lunch

Introductory Therapist Workshop

Introductory Therapist Workshop.
Pre-workshop preparation.
You come to the workshop knowing the underlying theory and principles, and are ready to learn skills through experiential exercises.
The workshop will take place from 9:30am to 5:00pm on both 16th and 17th November including a lunch break.

NOTE: This Introductory Workshop is open to doctors, therapists, patients and other interested members of the public.

Psychologist

Summit:16 CPD Hours Non-APS CPD event.
Therapist Training:16 CPD Hours Non-APS CPD event.
Combined Summit & Training: 32 CPD Hours Non-APS CPD event.

Social Worker

Summit:16 CPD Hours Non Accredited - MHSW and AASW CPD event.
Therapist Training:16 CPD Hours Non Accredited - MHSW and AASW CPD event.
Combined Summit & Training: 32 CPD Hours Non Accredited- MHSW and AASW CPD event.

Psychiatrist

Summit:16 CPD Hours NON-RANZCP accredited CPD event.
Therapist Training:16 CPD Hours NON-RANZCP accredited CPD event.
Combined Summit & Training: 32 CPD Hours NON-RANZCP accredited CPD event.

General Practitioners

Summit:32 CPD Hours Non-Accredited CPD event.
Therapist Training: 32 CPD Hours Non-Accredited CPD event.
Combined Summit & Training: 64 CPD Hours Non-Accredited CPD event.

^* Tickets will be available unless sold-out in previous ticket release rounds.

Be the first to know when the tickets go on sale and save with the Early Bird discounts:

Poster, Scholarships and Young Leaders Applications

Poster Presentations ►

Call for Poster Presentations

Submissions are invited for poster presentations that represent original and new, important or relevant science, research, technology, clinical application or public health projects relating to one or more of the themes of medicine-assisted therapies for mental illness, or relevant to the field of psychedelic medicine.

Key date for submission: No later than 30 June. We will be assessing posters on merit after June 30 2020.

Who should apply?

Scientists and researchers
Psychologists and therapists
Medical practitioners
Academics in the fields of anthropology, philosophy, ethics, law, policy or other related disciplines
Post-graduate students and research fellows
Public health professionals
Anyone with the drive and capability to bring new projects and ideas to the field

What can be on a poster?

Preliminary research findings
New, evidence-based research or treatment proposals
A project or idea that advances the field of medicine-assisted therapy scientifically, socially, philosophically, ethically or therapeutically.

**This could include a project that is not related to research or treatment but would benefit the field in some direct way.

Poster Presentations

Several poster presentations will be invited to present a short “2020” talk about the topic area of their submission as part of the main Summit program. Each presentation will include 20 slides lasting 20 seconds each.

All other successful applicants will be invited to be available to present their poster in a separate area at specific times during the Summit.

Awards

As decided by the Mind Medicine Australia Advisory Panel, awards will be presented for the best poster presentations during the closing plenary session of the International Summit on Psychedelic Therapies for Mental Illness.

About the submission process

Posters received will be de-identified before being assessed and ranked against selection criteria drawn up by the Scientific Committee including:

The extent to which the content relates to the themes of the Summit or is relevant to the field
The extent to which the poster represents new, original, innovative or important research proposals and preliminary results
The scientific, technical, academic and/or clinical rigour of the work

The extent this research, program or idea proposes a novel, viable and high impact opportunity for the field Posters will be displayed on boards in an allocated area for the duration of the conference.

Conditions of acceptance

All poster presentations must be presented by one of the listed abstract authors.
Any costs of presenting (including conference registration, travel and accommodation) are the responsibility of the presenter, except where a student scholarship may cover certain costs.
Submission of an abstract/poster confers permission to publish it in the official Summit publications.
Poster presenters are required to bring their poster to the Summit venue with them, and will be advised of the time and date by which posters should be displayed.
Poster presenters are required to stand near their posters during allocated poster viewing times across the Summit to engage with conference delegates.
To be considered for a Poster Presentation, you will need to have purchased a ticket for the Summit.

Apply Now

Scholarships ►

Several Student Scholarships are available to eligible undergraduate and postgraduate students to receive a complimentary registration to the 2020 MMA Global Summit.

Eligible applicants include medical students, GP/hospital registrars, science and research students, public health students, and students of allied health disciplines, ethics, law, policy, anthropology and other related disciplines.

Students wishing to be considered for a Student Scholarship are required to submit an abstract or original piece of work (up to 1500 words) to the Conference committee. Suitable original pieces include articles, case studies or discussions that address one or more of the conference themes. This may be the same as your poster submission. Please note that all applications must be accompanied by the official Submission Form for abstracts and scholarships. Incomplete or incorrect applications will not be accepted.

Apply Now

Young Leaders ►

Both poster and scholarship applicants will also be eligible to apply as a Young Leader. Young Leaders are applicants of 35 years of age or under who are currently involved in research, a related project or have an incredible idea that will contribute to the field of psychedelic medicine in an innovative or integral way.

Successful Young Leaders will be invited to form the inaugural membership of a new committee within Mind Medicine Australia for 2021 that activates the talent and enterprise of emerging talent to support the development of psychedelic medicines in Australia.

Additionally, several successful Young Leaders will be invited to present a short (5 minute) talk as part of the main conference program.

To be eligible for appointment as a Young Leader please select this option on the poster or scholarship application form and let us know why you would like to join Mind Medicine Australia as a Young Leader in 2021.

Conditions of acceptance

To be considered as a Young Leader, you will need to have purchased a ticket for the Summit.

Apply Now

Who should attend

► Titles:

Academic / Professor / Dean
Anthropologist
Chief Agricultural Officer
Chief Executive Officer
Chief Financial Officer
Chief Innovation Officer
Chief Investment Officer
Chief Medical Officer
Chief Policy Advisor
Chief Research Officer
Chief Science Officer
Clinician / Therapist / Psychotherapist
Consumer
Doctor / General Practitioner / Specialist
Drug and Alcohol Counsellor
Emerging Leaders
Entrepreneur
Executive Director
General Counsel
General Manager
Government Affairs
Head of Corporate Development
Interested Citizen
Lawyer
Lobbyist
Management Consultant
Managing Director
Mental Health Professional
Nurse
Partner
Patient
Pharmacist
Politician
Principal
Psychiatrist
Psychologist
Public Health Professional
Public Servant
Regulator
Scientist
Start-up
Founder
Philanthropist

► Head of:

Agriculture
Clinical Trials
Commercialisation
Development
Finance
General Practice
Investment
Law
Management Consulting
Manufacturing
Medical Affairs
Medicine
Mental Health
Partnerships
Pharmacy
Policy
Project Management
Regulatory Affairs
Regulatory Affairs
Research
Science
Strategy

► Industry:

Agribusiness
Agricultural Science
Biotech
Charities
Clinical Trials
Finance
Government
Hedge Funds
Hospital Systems
Insurance Companies
Legal
Management Consulting
Medicine
Mental Health Organisations
Not-for-Profits
Nursing
Pharma
Philanthropy
Private Equity
Professional Services
Psychedelic Medicine Organisations
Public Health
Publicly Listed Companies
Venture Capital

Accommodation

Summit venue

Sofitel Melbourne On Collins ★★★★★

25 Collins Street, 3000, Melbourne

Sofitel Classic King Room At the Paris-end of Collins Street, this 5 star hotel is close to shopping outlets, art, business, and signature destinations including the Melbourne Cricket Ground (MCG), Melbourne Tennis Centre, Federation Square, National Gallery of Victoria (NGV) and Princess & Regent Theatres. The hotel’s luxurious rooms and suites begin from level 36 offering floor-to-ceiling views that stretch across the city skyline, bay and beyond. Each room is complemented by modern furnishings, high speed wireless or cable internet, an executive desk and integrated ‘touch’ technology for ambient lighting modes and digital surround sound.

For reservations please email H1902@sofitel.com or call 03 9653 0000 with the following information:

Group Code: MM151120G
Room: King or Twin – Classic Room Type
Special Guest Rate: $330.00 room only / $355.00 including buffet breakfast for 1 / $380.00 including buffet breakfast for 2

Please note, accommodation room type and rates are subject to availability at time of booking. Credit Card details are required to guarantee the booking. Download the Credit Card Authorisation Form here (PDF, 99KB).

The Reservation Department is open Monday to Friday from 8am-8pm and Saturday and Sunday 9.30am – 6pm.

Pullman Melbourne On the Park ★★★★★

192 Wellington Parade, 3002, Melbourne

Pullman Melbourne On the Park Discounted rate for our Superior rooms at a rate of $219.00 per room, per night, room only available from 15-18 November 2020.

All rooms are subject to availability at the time of booking. Should the room type quoted be unavailable, the group rate will be available for the next room category at the Hotel's standard upgrade prices.

Delegates will be able to contact the reservations team with a special group code: 153451 to book their rooms. Reservations can be contacted on h9875@accor.com

This rate carries a 24 hour cancellation policy, and a credit card will be required at the time of booking to secure the reservation.

Please note - The rates and room types quoted are based on current availability and are subject to change without notice.

Become a Partner

Illustration about the benefits of parnering

The Mind Medicine Australia program will provide your organisation with a a unique opportunity to be profiled with this world class event and receive a host of benefits to enable engagement, conversation, and education for your leaders, emerging talent and stakeholders.

The program will give a limited number of organisations a range of benefits, including an opportunity to leverage the promotional campaign in the lead up to the Mind Medicine Australia 2020 International Summit, offer preferential and complimentary tickets, access to key speakers, and special Summit activities.

Benefits will include:

Identification as a Partner for the Mind Medicine Australia 2020 International Summit. This is a prestigious, high level national and international event for leaders and other decision makers.
Profiling in the program (at various levels) and the communications and website of Mind Medicine Australia.
The opportunity to educate and engage your staff, leaders and emerging talent individually or through sending teams via rewards/scholarships. Build new capabilities, enhance innovative thinking, and prepare for a new paradigm in mental health treatment.
Engagement of key stakeholders by offering VIP guest passes to the Mind Medicine Australia 2020 Summit.
Profile your organisation within email, social media, and press communications in the lead up to and during the Mind Medicine Australia 2020 Summit.
Access to papers and articles by our global presenters for your newsletters, magazines and journals, ongoing education, social media and web e-news.
Access to key Australian-based leaders who will be available for presentations, luncheons, seminars, workshops and events leading up to the event.
Opportunities to engage international speakers for presentations at luncheons, dinners, seminars, workshops and events around the Mind Medicine Australia 2020 event period.
Opportunities for your organisation to present interactive conversation circles (‘Hot Spots’)_on topics to suit key themes, providing a great discussion forum.
We are open to your creative thoughts to further leverage this event for a range of mutual benefits.

For enquiries and to confirm a partnership, please contact us ASAP at tania@mindmedicineaustralia.org

International Summit on Psychedelic Therapies for Mental Illness

2 Day Introductory Therapist Workshop+ 2 Day Public Summit

Second release tickets deadline (June 30)

Speakers

Professor David Nutt (UK)

Professor David Nutt (UK)

John Skerrit

John Skerrit

Dr Rick Doblin (USA)

Dr Rick Doblin (USA)

Wade Davis CM (Canada)

Wade Davis CM (Canada)

Dr Robin Carhart-Harris (UK)

Dr Robin Carhart-Harris (UK)

Professor Janis Phelps (USA)

Professor Janis Phelps (USA)

Dr Ben Sessa (UK)

Dr Ben Sessa (UK)

Professor Dan Ariely (USA/Israel)

Professor Dan Ariely (USA/Israel)

Associate Professor Matthew Johnson (USA)

Associate Professor Matthew Johnson (USA)

Maria Papaspyrou (UK)

Maria Papaspyrou (UK)

Adam Gazzaley M.D, PHD (USA)

Adam Gazzaley M.D, PHD (USA)

Shlomi Raz (USA)

Shlomi Raz (USA)

Renee Harvey (UK)

Renee Harvey (UK)

Professor David Castle

Professor David Castle

Dr Lisa Reynolds (NZ)

Dr Lisa Reynolds (NZ)

Dr Simon Longstaff AO

Dr Simon Longstaff AO

Tania de Jong AM

Tania de Jong AM

Peter Hunt AM

Peter Hunt AM

Recommend a Speaker

Your details

Information about the person you are recommending to speak at this event:

Tickets

YOUR 2020 SUMMIT PACKAGE (Platinum, Gold, Silver) includes:

Introductory Therapist Workshop

Psychologist

Social Worker

Psychiatrist

General Practitioners

Poster, Scholarships and Young Leaders Applications

Poster Presentations ►

Call for Poster Presentations

Who should apply?

What can be on a poster?

Poster Presentations

Awards

About the submission process

Conditions of acceptance

Scholarships ►

Young Leaders ►

Conditions of acceptance

Who should attend

Demographics by location

Accommodation

Sofitel Melbourne On Collins ★★★★★

Pullman Melbourne On the Park ★★★★★

Proudly supported by:

Become a Partner

Benefits will include:

Summit Program Overview

Therapist Workshop Overview

MMA Summit - Event Applications

About You

Poster Presentations

Scholarships

Terms & Conditions

Privacy Notice

Program

2 Day Introductory Therapist Workshop
+ 2 Day Public Summit